Mount Lebanon Hospital University Medical Center

What Mount Lebanon Hospital University Medical Center does

Mount Lebanon Hospital University Medical Center (MLHUMC) is a private tertiary medical center located in Hazmieh, Lebanon, operating a 400-bed campus with 12 pediatric life-support stations. It is 100% Lebanese-owned and has served as the University Medical Center of Balamand University since 2019. The hospital is led by the Gharios family: Elie Gharios (President and Medical Director), Nazih Gharios (CEO and General Director), and Roula Gharios Zahar (Deputy General Director, Finance and Quality Director). MLHUMC has earned the Joint Commission International (JCI) Gold Seal of Approval four consecutive times, most recently in October 2025, making it the only JCI-accredited university medical center in Lebanon with full domestic ownership.

The hospital's core service portfolio centers on comprehensive cancer care — radiation oncology equipped with TrueBeam STx and HALCYON linear accelerators (described as unique in the Middle East), chemotherapy and immunotherapy, and a relaunched autologous stem cell transplantation program — alongside advanced surgical services that include awake craniotomy with neuro-navigation, cardiac, vascular, and reconstructive surgery. Women's health is anchored by IVF Azoury Clinics (reopened November 2025 with upgraded fertility technology), maternity services, and non-invasive prenatal testing (NIPT). The institution also runs nuclear medicine, home care, and approximately 59 international clinical trials per year through its partnership with Clinerion's Patient Network Explorer, and has piloted AI-based chest X-ray triage for lung cancer detection using Qure.ai algorithms in collaboration with AstraZeneca.

MLHUMC generates revenue principally through fee-for-service tertiary medical care delivered across inpatient, outpatient, home-care, and diagnostic channels within Lebanon, supplemented by professional-services revenue from international clinical trial participation. Pricing is quote-based with no public tariff. The hospital markets through a multi-channel mix including a multilingual website (English, Arabic, French), social platforms, WhatsApp direct lines, health-information content, and the annual Lebanese Oncology Forum. A $53M expansion project is underway to extend capacity and service offerings.

Name

Mount Lebanon Hospital University Medical Center

Legal name

Mount Lebanon Hospital University Medical Center

Website

https://mlh.com.lb

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Mount Lebanon Hospital University Medical Center is a 400-bed private tertiary hospital in Hazmieh, Lebanon, serving Lebanese and MENA patients with advanced oncology, surgery, women's health, and clinical-trial services, operated by Balamand University and JCI-accredited four times.

Ownership category

akta.pro rank

Product category

Tertiary Healthcare Services

NAICS

General Medical and Surgical Hospitals (622110), Medical and Diagnostic Laboratories (62151)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Medical Laboratories (8071)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

akta.pro secondary industries

Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring) (HLAAABAJ), Lung Cancer Screening & Pulmonary Nodule Clinic (HLAKANAI), Clinical Research & Trial Central Laboratories (HLAFAMAL)

Keywords

• Tertiary healthcare services
• Radiation oncology
• Clinical trials participation
• Fertility and maternity services
• Advanced surgical services

Headquarters

HQ city

Beirut

HQ country

Lebanon

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Medical Services and Hospital Care: Tertiary medical center providing healthcare services across all medical specialties including inpatient care, outpatient clinics, emergency medicine, surgery, and diagnostic services
2. Clinical Trial Services: As a clinical trial site, MLHUMC performs 59 trials per year, generating revenue through participation in international clinical research

Distribution channels4 records

Marketing channels11 records

Core offering

MLHUMC is a 400-bed private tertiary medical center delivering comprehensive inpatient and outpatient care across all medical specialties, with particular depth in radiation oncology (TrueBeam STx and HALCYON), chemotherapy/immunotherapy, stem cell transplantation, advanced surgery including awake craniotomy, women's health (IVF Azoury Clinics, maternity, NIPT), nuclear medicine, and home care. The hospital also acts as an international clinical trial site, running approximately 59 trials per year through the Clinerion Patient Network Explorer, and is piloting AI-assisted lung cancer early detection.

Product overview

Mount Lebanon Hospital University Medical Center (MLHUMC) is a private tertiary care hospital offering medical services across all specialties. Its core portfolio centers on comprehensive cancer care (radiation oncology with TrueBeam STx and HALCYON, chemotherapy, immunotherapy, stem cell transplantation), advanced surgical services (including awake craniotomy with brain mapping, cardiac, vascular, and plastic surgery), women's health (IVF Azoury Clinics, maternity, NIPT prenatal screening), nuclear medicine, and home care. The hospital runs approximately 59 clinical trials per year through its Clinerion partnership and is piloting AI-powered chest X-ray analysis for early lung cancer detection with Qure.ai. Services are delivered across 12 pediatric life support stations with 400-bed capacity.

Differentiator

Problem solved

Functional benefit

Products and services

• Radiation Oncology Center Comprehensive radiation oncology platform equipped with TrueBeam STx and HALCYON linear accelerators (unique in the Middle East), offering IMRT/VMAT, SRS, SBRT, and image-guided adaptive brachytherapy for adult and pediatric cancer patients.
• Chemotherapy & Immunotherapy Services In-house chemotherapy, targeted therapy, and immunotherapy (including FDA-approved immunotherapy drugs) administered by the Oncology and Hematology Department for cancer patients.
• Clinical Trials Program Active clinical trial site conducting approximately 59 trials per year through the Clinerion Patient Network Explorer, providing patients with accelerated access to innovative therapies via international clinical trials.
• Surgical Services Full-spectrum surgical services including awake craniotomy for brain tumors near eloquent brain areas, cardiac surgery, vascular surgery, general surgery, and plastic/reconstructive surgery, performed in operating theaters at MLHUMC.
• Stem Cell Transplantation Program Autologous stem cell transplantation program for lymphoma and multiple myeloma, relaunched in June 2025 with six successful transplants performed over four months.
• IVF Azoury Clinics In vitro fertilization department with newly upgraded facilities and latest fertility technologies, officially reopened at MLHUMC in November 2025.
• Home Care Services Medical care services delivered to patients in their homes, extending the hospital's reach beyond its physical facility.
• Non-Invasive Prenatal Test (NIPT) Non-invasive prenatal screening using SNP (Single Nucleotide Polymorphism) technology on maternal blood to detect fetal chromosomal abnormalities including Trisomy 21 (Down syndrome), Trisomy 13, Trisomy 18, microdeletions, and fetal gender from the 9th–12th week of pregnancy, with sensitivity and specificity above 99.9%.
• Nuclear Medicine Department Nuclear medicine services including radioactive iodine treatment for thyroid conditions, with published research on patient organ dose assessment during radioactive iodine treatments.
• Varicose Veins Clinic Specialist clinic offering duplex ultrasound diagnosis and treatment options for varicose veins including ultrasound-guided foam sclerotherapy (UGFS), mechanochemical ablation (MOCA/Clarivein), and endovenous laser therapy (EVLT).
• Awake Craniotomy with Brain Mapping Neurosurgical procedure performed while the patient is awake, using intraoperative cortical and subcortical electrical mapping for resection of brain tumors in eloquent areas, employing neuro-navigation and asleep-awake-asleep (AAA) or MAC anesthesia techniques.
• Maternity Services Obstetrics and gynecology services including prenatal care, delivery, and postpartum support, with access to NIPT screening and IVF services.

Quantifiable outcome

• Six autologous stem cell transplants successfully performed within four months of program relaunch (June 2025)
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability3 records

Feature5 records

Partnerships

Three partnerships are on record, tiered core and minor.

• AstraZenecacoreStrategic or Co-development Partner · 13 December 2022AstraZeneca and MLHUMC are piloting a study on the use of artificial intelligence to enhance early-stage diagnosis of lung cancer, improve management, and reduce mortality rates. MLHUMC is piloting deep learning algorithms for chest X-rays as part of a global study to detect lung cancer earlier.
• ClinerioncoreTechnology or Integration · 8 November 2022MLHUMC partnered with Clinerion joining the global network of partner hospitals on Clinerion's Patient Network Explorer. This partnership accelerates patient access to innovative therapies via participation in international clinical trials. MLHUMC gains access to metrics supporting patient care, and Lebanon benefits from early data to support registration of new therapies.
• MarPe CROminorImplementation/ SI/ Consulting Partner · 8 November 2022MarPe (full service Contract Research Organization headquartered in Cairo, Egypt with a branch in Nairobi, Kenya) was instrumental in facilitating the partnership between MLHUMC and Clinerion as one of their alliances in the MENA and Africa region.

Scale indicators6 records

Recent moves7 records

Expansion highlights4 records

Broad incumbents

• Burjeel Holdings: Large private tertiary hospital and clinic operator across the UAE and MENA including advanced oncology. Comparable to MLHUMC as a private-sector MENA tertiary platform competing for cross-border specialty patient flows.
• Saudi German Hospital Group: One of the largest private hospital networks in MENA with tertiary hospitals in Saudi Arabia, UAE, Egypt, and Yemen. Comparable to MLHUMC as a private tertiary hospital group with JCI-accredited centers and oncology services across the region.
• Cleveland Clinic Abu Dhabi: Multi-specialty academic tertiary hospital in the UAE operated under the Cleveland Clinic brand. Comparable to MLHUMC on JCI-standard tertiary care, advanced oncology/surgery, and aspiration to attract regional and international patients.

Direct peers

• Hotel Dieu de France: JCI-accredited university hospital in Beirut affiliated with Université Saint-Joseph. Closely comparable to MLHUMC on geography, JCI-accredited university status, and broad tertiary specialty offering including oncology and surgery.
• American University of Beirut Medical Center (AUBMC): One of only two JCI-accredited university hospitals in Lebanon and the region's largest academic medical center. Comparable to MLHUMC as a Lebanese tertiary university hospital with comprehensive specialty coverage and a research/clinical trial footprint.
• Clemenceau Medical Center (CMC) Beirut: JCI-accredited private tertiary hospital in Beirut affiliated with Johns Hopkins Medicine International. Directly comparable to MLHUMC as a Lebanese JCI-accredited tertiary center competing for similar specialty and international patient flows.
• King Hussein Cancer Center (KHCC): Leading tertiary cancer center in Amman, Jordan with advanced radiation oncology and autologous stem cell transplantation programs. Comparable to MLHUMC's oncology-led positioning and regional medical-tourism draw for cancer care.

Regional players

• Hammoud Hospital University Medical Center: JCI-accredited university hospital in southern Lebanon (Saida). Comparable to MLHUMC as a Lebanese JCI-accredited university hospital serving tertiary care and complex cases; competes for patients in overlapping specialties.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/mlhumc
• YouTubeyoutube.com/channel/UCzjVu8cMtgEZeVSlxnn6lCQ
• Facebookfacebook.com/mountlebanonhospital
• LinkedInlinkedin.com/company/mount-lebanon-hospital
• Instagraminstagram.com/mountlebanonhospital

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mount Lebanon Hospital University Medical Center